Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
53.91-0.08 (-0.15%)
At close: 04:03PM EDT
53.87 -0.04 (-0.07%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close50.65
Open51.26
Bid53.87 x 1800
Ask53.98 x 4000
Day's Range51.13 - 52.70
52 Week Range38.48 - 61.71
Volume21,000,785
Avg. Volume27,271,677
Market Cap302.59B
Beta (5Y Monthly)0.72
PE Ratio (TTM)15.40
EPS (TTM)3.50
Earnings DateMay 02, 2022 - May 06, 2022
Forward Dividend & Yield1.60 (3.21%)
Ex-Dividend DateMay 12, 2022
1y Target Est59.33
  • Reuters

    U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

    Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time. More quarantine time "is not a crowd-pleaser," Dr. Sandra Kemmerly, an infectious disease specialist at Ochsner Health in New Orleans, told Reuters. Use of Pfizer's Paxlovid, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared as infections have risen.

  • Insider Monkey

    Top 10 Value Stocks Hedge Funds are Buying in 2022

    In this article, we discuss the top 10 value stocks hedge funds are buying in 2022. If you want to see more of the value stocks that elite investors are favoring, click Top 5 Value Stocks Hedge Funds are Buying in 2022. As the Federal Reserve signals further monetary tightening, hedge funds and retail investors […]

  • Zacks

    Pfizer (PFE) Gets Fast Track Designation for NASH Therapy

    Pfizer (PFE) obtains Fast Track designation for its investigational combination therapy - ervogastat and clesacostat for the treatment of NASH.

Advertisement
Advertisement